Clinical Trials · NCT01507285
Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 24
- Start date
- Aug 1999
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Area under the Curve